MicroRNA-122 mimic/microRNA-221 inhibitor combination as a novel therapeutic tool against hepatocellular carcinoma

BACKGROUND: Therapeutic microRNAs (miRNAs) delivery holds a lot of promise for treating human malignancies. So, this study was carried out to examine the potential of miR-122 mimic and/or miR-221 inhibitor as an innovative therapeutic strategy for HCC in an animal model. METHODOLOGY: Mice were categ...

Descripción completa

Detalles Bibliográficos
Autores principales: Hassan, Marwa, Elzallat, Mohamed, Aboushousha, Tarek, Elhusseny, Yasmine, El-Ahwany, Eman
Formato: Online Artículo Texto
Lenguaje:English
Publicado: KeAi Publishing 2022
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9713283/
https://www.ncbi.nlm.nih.gov/pubmed/36474748
http://dx.doi.org/10.1016/j.ncrna.2022.11.005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9713283/
https://www.ncbi.nlm.nih.gov/pubmed/36474748
http://dx.doi.org/10.1016/j.ncrna.2022.11.005

Ejemplares similares